$115MSeries D, 11 August 2025
Series D separate from $25M Series C tranche; funds commercialization
- Amount
- $115M
- Stage
- Series D
- Announced
- 11 August 2025
- Lead
- Elevage Medical Technologies
- Other investors
- Ally Bridge Group, Northwell Health, SPRIG Equity
- Use of funds
- Series D separate from $25M Series C tranche; funds commercialization
- Checked
- Announced by the company
- Sources
- SetPoint Medical raises $115M Series D (plus $25M Series C tranche = $140M total) for arthritis neuroimmune th setpointmedical.com
SetPoint Medical raises $115M Series D (plus $25M Series C tranche = $140M total) for arthritis neuroimmune th news.crunchbase.com